GlassScriptPhysician profile
Akshay Shetty
NPI 1265790687
$17,514.63
in general payments reported to CMS, 2019-2025
14 companies · $11K in 2025
The $11K reported for 2025 was more than what 93% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.09 · 2020: $666 · 2021: $979 · 2022: $266 · 2023: $860 · 2024: $3,421 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,700 · Honoraria: $2,760 · Food and Beverage: $2,184 · Travel and Lodging: $946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,700.00 |
| Honoraria | $2,760.00 |
| Food and Beverage | $2,183.93 |
| Travel and Lodging | $946.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $7,858.46 | 2024-2025 | Rezdiffra, Resmetirom |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $3,687.50 | 2020-2025 | Xifaxan |
| Ipsen Biopharmaceuticals, INC | $2,834.02 | 2024-2025 | Bylvay, Iqirvo |
| Gilead Sciences, INC. | $2,165.15 | 2020-2025 | |
| Abbvie INC. | $248.53 | 2020-2024 | |
| Fujifilm Healthcare Americas Corporation | $167.41 | 2021 | |
| Mirum Pharmaceuticals, INC. | $136.39 | 2023 | Livmarli |
| Sequana Medical US INC. | $133.86 | 2025 | Alfapump System |
| Orphalan INC | $127.66 | 2023 | Cuvrior |
| Alnylam Pharmaceuticals INC. | $83.39 | 2022-2023 | Givlaari, Oxlumo |
| Shionogi INC | $30.64 | 2019-2020 | |
| Intra-Sana Laboratories | $21.53 | 2021 | |
| Merck Sharp & Dohme LLC | $20.09 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akshay Shetty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.